Not just a nursing home problem: Antipsychotic use increasing in elderly, community-dwelling dementia patientsApril 24, 2018
While regulatory focus has pushed the use of antipsychotics lower in skilled nursing facilities recently, off-label use is rising among dementia patients living in assisted living and other community settings.
In response to a recent report from the Office of the Inspector General, a prominent psychiatrist is defending the practice of prescribing antipsychotic medications for nursing home residents with dementia.
AstraZeneca settles for $520 million following investigation into improper marketing of anti-psychotic drugApril 28, 2010
Pharmaceutical giant AstraZeneca has agreed to pay $520 million to end a federal investigation into its alleged illegal marketing of the drug Seroquel for off-label uses, according to reports from Washington.
A large number of physicians don't know when they are prescribing drugs, including antipsychotics, "off-label," according to a recent report.